EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm

Nesrine Lajmi iD, Sofia Alves-Vasconcelos, Apostolos Tsiachristas, Andrew Haworth, Kerrie Woods, Charles Crichton, Theresa Noble, Hizni Salih, Kinga A Várnai, Harriet Branford-White, Liam Orrell, Andrew Osman und 6 weitere

Cambridge Prisms: Precision Medicine · 2024 · 2

DOI: 10.1017/pcm.2024.1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, online erschienen am 26.03.2024. Verfasst von Nesrine Lajmi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostics Division, Roche Information Solutions, F. Hoffmann-La Roche Ltd., Basel, Switzerland. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The personalised oncology paradigm remains challenging to deliver despite technological advances in genomics-based identification of actionable variants combined with the increasing focus of drug development on these specific targets. To ensure we continue to build concerted momentum to improve outcomes across all cancer types, financial, technological and operational barriers need to be addressed. For example, complete integration and certification of the ‘molecular tumour board’ into ‘standard of care’ ensures a unified clinical decision pathway that both counteracts fragmentation and is the cornerstone of evidence-based delivery inside and outside of a research setting. Generally, integrated delivery has been restricted to specific (common) cancer types either within major cancer centres or small regional networks. Here, we focus on solutions in real-world integration of genomics, pathology, surgery, oncological treatments, data from clinical source systems and analysis of whole-body imaging as digital data that can facilitate cost-effectiveness analysis, clinical trial recruitment, and outcome assessment. This urgent imperative for cancer also extends across the early diagnosis and adjuvant treatment interventions, individualised cancer vaccines, immune cell therapies, personalised synthetic lethal therapeutics and cancer screening and prevention. Oncology care systems worldwide require proactive step-changes in solutions that include inter-operative digital working that can solve patient centred challenges to ensure inclusive, quality, sustainable, fair and cost-effective adoption and efficient delivery. Here we highlight workforce, technical, clinical, regulatory and economic challenges that prevent the implementation of precision oncology at scale, and offer a systematic roadmap of integrated solutions for standard of care based on minimal essential digital tools. These include unified decision support tools, quality control, data flows within an ethical and legal data framework, training and certification, monitoring and feedback. Bridging the technical, operational, regulatory and economic gaps demands the joint actions from public and industry stakeholders across national and global boundaries.

Schlagwörter

Stichwörter der Autor:innen

cost-effectivenesshealth datainteroperabilitypatient centredpatient recordprecision medicineprecision oncologystandard of care

Autor:innen und Institutionen

  • Diagnostics Division, Roche Information Solutions, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
  • Oxford Molecular Pathology Institute, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK.
  • Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Roche Healthcare Consulting, Roche Diagnostics Limited, West Sussex, UK.
  • Wales Research and Diagnostic PET Imaging Centre, University Hospital of Wales, Cardiff, UK.

ORCID-Profile: Nesrine Lajmi

Zitieren

APA

Lajmi, N., Alves-Vasconcelos, S., Tsiachristas, A., Haworth, A., Woods, K., Crichton, C., Noble, T., Salih, H., Várnai, K. A., Branford-White, H., Orrell, L., Osman, A., Bradley, K. M., Bonney, L., McGowan, D. R., Davies, J., Prime, M. S., & Hassan, A. B. (2024). Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm. Cambridge Prisms: Precision Medicine, 2. https://doi.org/10.1017/pcm.2024.1

Vancouver

Lajmi N, Alves-Vasconcelos S, Tsiachristas A, Haworth A, Woods K, Crichton C, et al. Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm. Cambridge Prisms: Precision Medicine. 2024;2. doi:10.1017/pcm.2024.1

BibTeX
@article{Lajmi2024,
  author = {Lajmi, Nesrine and Alves-Vasconcelos, Sofia and Tsiachristas, Apostolos and Haworth, Andrew and Woods, Kerrie and Crichton, Charles and Noble, Theresa and Salih, Hizni and Várnai, Kinga A and Branford-White, Harriet and Orrell, Liam and Osman, Andrew and Bradley, Kevin M and Bonney, Lara and McGowan, Daniel R and Davies, Jim and Prime, Matthew S and Hassan, Andrew Bassim},
  title = {Challenges and solutions to system-wide use of precision oncology as the standard of care paradigm},
  journal = {Cambridge Prisms: Precision Medicine},
  year = {2024},
  volume = {2},
  doi = {10.1017/pcm.2024.1}
}
Kostenlos starten →